
This study aimed to develop and internally validate a nomogram for predicting clinically significant prostate cancer (csPCa). The significant variables associated with csPCa included Prostate Imaging Reporting and Data System (PI-RADS), smaller prostate volume, and prostate-specific antigen (PSA) levels >10 ng/mL. The nomogram exhibited excellent accuracy in discriminating csPCa and demonstrated clinical utility in reducing unnecessary biopsies.
Like
Save
Share